Vast Therapeutics is a Durham, North Carolina-based airway immunology company pioneering a novel approach to treating chronic respiratory diseases.

We are dedicated to developing breakthrough medicines, leveraging our proprietary nitric oxide technology, to address the root causes of debilitating conditions like cystic fibrosis, bronchiectasis, and NTM lung disease. Our technology, based on stable prodrugs of nitric oxide, offers a unique ‘antimicrobial alternative’ resistant to common antibiotic resistance mechanisms.

Founded in 2017 and currently employing 11 people, Vast Therapeutics is committed to improving the lives of patients suffering from chronic lung disease. We are focused on advancing our pipeline through preclinical and clinical development, with a strong scientific advisory board and a dedicated team of experts.

Our team combines decades of experience in pharmaceutical development, respiratory medicine, and drug delivery, driving innovation and translating scientific breakthroughs into impactful therapies.

Inhaled Therapy ALX1 | Vast Therapeutics

Service description

Vast Therapeutics Durham, United States (US)

Price: N/A

Vast Therapeutics
Durham, United States (US)